Lilly Acquiring Kelonia In Largest Funded Biotech Startup Purchase In Years
THE SO WHAT
Lilly paying up to $7B in cash for Kelonia’s gene therapy platform is a signal that platform biotech with clear oncology angles is back to strategic-asset pricing, not just pipeline math. If you’re building in therapeutics or tools, assume big pharma will pay for differentiated delivery and modality platforms—structure your data and IP to be acquirable, not just fundable.
READ THE SOURCE
MORE FROM THE WIRE
Jeff Bezos' secretive AI startup is set to be valued at around $38 billion after raising a $10 billion mega round
A $10B raise into Project Prometheus at a $38B post-money says industrial AI is now its own capital stack—separate from consumer assistants and office copilots. If your AI roadmap is still framed around SaaS workflows instead of physical-world understanding and control, you’re building for the wrong demand curve.
Startups & VentureJeff Bezos Nears $10 Billion Funding for AI Lab, FT Says
Bezos backing a $10B lab focused on models that understand the physical world is a direct bet that industrial and robotics-grade perception will be the next profit pool. If your AI strategy is still text-and-slideware, expect to be outflanked by players training on factories, logistics, and machines instead of documents.
Startups & VentureSources: Jeff Bezos' Project Prometheus is close to a $10B fundraising deal, which includes an initial $6.2B raise in November, at a $38B post-money valuation (Financial Times)
A $10B raise at a $38B post-money for industrial AI says the next margin war is in factories and supply chains, not consumer assistants. If you're selling into industrials and don't have a Prometheus-level story on models, data rights, and integration, your 2027 pipeline is already at risk.
Startups & VentureAmazon to Invest an Additional $5 Billion in Anthropic
Another $5B into Anthropic is less about model bets and more about locking in AI demand to AWS—cloud providers are turning frontier labs into long-dated consumption contracts. If you’re an enterprise buyer, your AI vendor choice is now a de facto cloud choice; treat those negotiations as one integrated deal, not separate line items.